摘要目的为了更好地了解贝伐单抗疗法对复发性胶质瘤的血流和氧合状态的影响。材料与方法回顾性数据的评估由海德堡大学的当地伦理委员会批准支持(伦理批准文号:S-320/2012),未签订知情同意书。71例被诊断为复发性胶质瘤的病人治疗前的检查和开始接受贝伐单抗治疗后的第一次随访检查中均是接受常规MRI扫描和动态磁敏感增 Abstract Objective To better understand the effect of bevacizumab on the blood flow and oxygenation status of recurrent gliomas. Materials and Methods The retrospective data were evaluated with the approval of the local ethics committee at Heidelberg University (Ethics Approval No: S-320/2012) and no informed consent was obtained. 71 patients who were diagnosed with recurrent gliomas underwent pre-treatment examinations and the first follow-up examination after starting treatment with bevacizumab was routine MRI scans and dynamic magnetosensitive augmentation